or
forgot password
  • cancer clinical trials in columbus, OH

  • Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
    Ohio State University Medical Center
    Columbus, Ohio 43210
    Kidney Cancer
    Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum Chemotherapy
    Ohio State University Medical Center
    Columbus, Ohio 43210
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Prevention of Pegfilgrastim-Induced Bone Pain (PIBP)
    CCOP - Columbus
    Columbus, Ohio 43206
    Musculoskeletal Complications, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

    Trial Locations
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Riverside Methodist Hospital
    Columbus CCOP
    Doctors Hospital
    Grant Medical Center
    Mount Carmel Health Center West
    B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Doctors Hospital

    Trial Locations
    Doctors Hospital
    Grant Medical Center
    Mount Carmel Health Center West
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Azacytidine and Bortezomib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
    Columbus, Ohio 43210-1240
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL)
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
    Columbus, Ohio 43210-1240
    Chronic Lymphocytic Leukemia, CLL, Untreated, Front-line, First-Line, Initial Therapy
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    CCOP - Columbus

    Trial Locations
    CCOP - Columbus
    Doctors Hospital at Ohio Health
    Riverside Methodist Hospital Cancer Care
    Mount Carmel Health - West Hospital
    Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
    Grant Medical Center Cancer Care
    Zangmeister Center
    Lung Cancer
    Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
    Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
    Columbus, Ohio 43210-1240
    Leukemia
    Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2
    Ohio State University
    Columbus, Ohio 43210
    Critically Ill, Hyperglycemia
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Riverside Methodist Hospital

    Trial Locations
    Riverside Methodist Hospital
    Columbus CCOP
    Doctors Hospital
    Grant Medical Center
    Mount Carmel Health Center West
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Correlative Biomarker Study in Patients With Myeloproliferative Disorders
    Ohio State University
    Columbus, Ohio 43210
    Myeloproliferative Disease, Myelofibrosis, Idiopathic Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera
    CEP-701 (Lestaurtinib) in Myelofibrosis
    Ohio State University Medical Center
    Columbus, Ohio 43210
    Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera
    Phase II NCT w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer
    Ohio State University Medical Center
    Columbus, Ohio 43210
    Breast Cancer
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Riverside Methodist Hospital

    Trial Locations
    Riverside Methodist Hospital
    Columbus CCOP
    Doctors Hospital
    Grant Medical Center
    Mount Carmel Health Center West
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

    Trial Locations
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Riverside Methodist Hospital
    Columbus CCOP
    Doctors Hospital
    Grant Medical Center
    Mount Carmel Health Center West
    Mount Carmel East Hospital
    The Mark H Zangmeister Center
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Decitabine and Bortezomib in Treating Patients With Acute Myeloid Leukemia
    Ohio State University Medical Center
    Columbus, Ohio 43210
    Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
    Nationwide Children's Hospital
    Columbus, Ohio 43205-2696
    Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Liver Cancer, Neuroblastoma, Ototoxicity, Ovarian Cancer, Sarcoma
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Riverside Methodist Hospital Cancer Care
    Columbus, Ohio 43214
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    CCOP - Columbus

    Trial Locations
    CCOP - Columbus
    Doctors Hospital at Ohio Health
    Riverside Methodist Hospital Cancer Care
    Mount Carmel Health - West Hospital
    Grant Medical Center Cancer Care
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma
    The Ohio State University Medical Center
    Columbus, Ohio 43210
    Multiple Myeloma
    A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma
    Investigational Site 3
    Columbus, Ohio
    Malignant Solid Tumor, Lymphomas, Multiple Myeloma
    Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
    Ohio State University
    Columbus, Ohio 43210
    Multiple Myeloma and Plasma Cell Neoplasm
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
    Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
    Columbus, Ohio 43210-1240
    Lung Cancer
    Multiple Ascending Dose (MDX1105-01)
    Ohio State University
    Columbus, Ohio 43210
    Cancer, Multiple Indications
    FTY720 in Patients With Primary Progressive Multiple Sclerosis
    Ohio State University
    Columbus, Ohio 43210
    Primary Progressive Multiple Sclerosis
    Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
    Columbus, Ohio 43210-1240
    B-cell Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia